Toggle navigation
The MRCT Center and Harvard Catalyst collaborated on a series of COVID-19 general clinical research — “ Should I join” — flyers to prepare potential clinical trial participants (patients, friends/family members, parents/guardians, + children for recruitment + consent.
Find current Coronavirus public resources for patients and the research community HERE.
The MRCT Center has organized a COVID-19 Guidance Repository for MRCT Sponsors to offer the possibility that we may learn from others. Industry and academic institutions are welcome to share their resources. MORE
In response to the European Commission’s request for feedback regarding the General Data Protection Regulation (GDPR), Mark Barnes and Barbara Bierer, MRCT Center Faculty Co-directors, and Senior Advisor David Peloquin along with Rita Lawlor, Biobank Director & Research Coordinator, ARC-Net Research Centre, University of Verona, Italy, submitted feedback.
Diagnostic tests for COVID-19 are central to most proposed plans for relaxing physical distancing and related policies.
Listen to Dr. Deborah Zarin, MRCT Center Program Director of Advancing the Clinical Trial Enterprise and former director of ClinicalTrials.gov with Science Magazine journalist, Charles Piller on Science Friday discussing recent investigations on ClinicalTrials.gov reporting practices.
Discussion topics: 1) Legal and Regulatory Issues Related to COVID-19 in Human Subjects Research, 2) Foreign Influence in Clinical Research, 3) the Impact of Fraud and Abuse Laws on Clinical Research
Discussion Topic: Patient Advocacy in Clinical Trials
Discussion topic: TBD
